BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghasemi-rad M, Attaya H, Lesha E, Vegh A, Maleki-Miandoab T, Nosair E, Sepehrvand N, Davarian A, Rajebi H, Pakniat A, Fazeli SA, Mohammadi A. Ankylosing spondylitis: A state of the art factual backbone. World J Radiol 2015; 7(9): 236-252 [PMID: 26435775 DOI: 10.4329/wjr.v7.i9.236]
URL: https://www.wjgnet.com/1949-8470/full/v7/i9/236.htm
Number Citing Articles
1
Yuan-Yuan Chen. Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitisMedicine 2017; 96(9): e5993 doi: 10.1097/MD.0000000000005993
2
Annalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, Melissa Padovan, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Pier Borea, Marcello Govoni, Katia Varani. Role and Function of A2A and A3 Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid ArthritisInternational Journal of Molecular Sciences 2017; 18(4): 697 doi: 10.3390/ijms18040697
3
Cunyi WANG, Ji'an HU, Jiejun SHI. Role of Interleukin-36 in inflammatory joint diseasesJournal of Zhejiang University (Medical Sciences) 2023; 52(2): 249 doi: 10.3724/zdxbyxb-2023-0034
4
Renfang Han, Qing Xia, Shengqian Xu, Dazhi Fan, Faming Pan. Interleukin-23 receptor polymorphism (rs10889677 A/C) in ankylosing spondylitis: Meta-analysis in Caucasian and Asian populationsClinica Chimica Acta 2018; 477: 53 doi: 10.1016/j.cca.2017.11.038
5
Yuansheng Xu, Wei Jiang, Hui Zhang. Association between C‐reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplastyJournal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23343
6
Dan Huang, Jian Liu, Lei Wan, Yanyan Fang, Yan Long, Ying Zhang, Bingxi Bao. Identification of lncRNAs associated with the pathogenesis of ankylosing spondylitisBMC Musculoskeletal Disorders 2021; 22(1) doi: 10.1186/s12891-021-04119-6
7
Yong Ni, Chengrui Jiang. Identification of potential target genes for ankylosing spondylitis treatmentMedicine 2018; 97(8): e9760 doi: 10.1097/MD.0000000000009760
8
A. Ya. Dimitrenko, V. O. Omelchenko, E. A. Letyagina, M. A. Korolev. Impact of traditional and ankylosing spondylitisassociated risk factors on the formation of atherosclerotic lesions in the brachiocephalic arteriesThe Siberian Medical Journal 2020; 35(1): 117 doi: 10.29001/2073-8552-2020-35-1-117-124
9
Vered Rosenberg, Howard Amital, Gabriel Chodick, Freddy Faccin, Abdulla Watad, Dennis McGonagle, Omer Gendelman. Real-World Adherence and Drug Survival of Biologics among Patients with Ankylosing SpondylitisJournal of Clinical Medicine 2024; 13(15): 4480 doi: 10.3390/jcm13154480
10
Jeffrey R. Curtis, Kevin Winthrop, Rhonda L. Bohn, Robert Suruki, Sarah Siegel, Jeffrey L. Stark, Fenglong Xie, Huifeng Yun, Lang Chen, Atul Deodhar. The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan DatabasesACR Open Rheumatology 2021; 3(11): 743 doi: 10.1002/acr2.11316
11
S.G. Alkhatib, K.A. Shah, K.J. Abrams. Imaging of Calcifying and Ossifying Disorders of the SpineNeurographics 2021; 11(1): 49 doi: 10.3174/ng.2000051
12
Jürgen Braun, Xenofon Baraliakos, Atul Deodhar, Dominique Baeten, Joachim Sieper, Paul Emery, Aimee Readie, Ruvie Martin, Shephard Mpofu, Hanno B Richards. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 studyAnnals of the Rheumatic Diseases 2017; 76(6): 1070 doi: 10.1136/annrheumdis-2016-209730
13
Raju Vaishya, Vipul Vijay, Ifeanyi Charles Nwagbara, Amit K. Agarwal. Diffuse idiopathic skeletal hyperostosis (DISH) – A common but less known cause of back painJournal of Clinical Orthopaedics and Trauma 2017; 8(2): 191 doi: 10.1016/j.jcot.2016.11.006
14
Ji-Won Kim, Sunghoon Park, Ju-Yang Jung, Hyoun-Ah Kim, Seong-Ryul Kwon, Sang Tae Choi, Sung-Soo Kim, Sang-Hyeon Kim, Chang-Hee Suh. Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment ToolJournal of Clinical Medicine 2022; 11(10): 2830 doi: 10.3390/jcm11102830
15
Joachim Sieper, Atul Deodhar, Helena Marzo-Ortega, Jacob A Aelion, Ricardo Blanco, Tseng Jui-Cheng, Mats Andersson, Brian Porter, Hanno B Richards. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 StudyAnnals of the Rheumatic Diseases 2017; 76(3): 571 doi: 10.1136/annrheumdis-2016-210023
16
Omar Larentis, Enrica Tonina, Chiara Tesi, Chiara Rossetti, Ilaria Gorini, Rosagemma Ciliberti, Marta Licata. A probable case of subligamentous tuberculous spondylitis: The concealed body of theLate Modern Period(early 16th century to early 20th century),Franciscancrypt ofSt. AnthonyandSt. Eusebiuschurch,Lombardy,ItalyInternational Journal of Osteoarchaeology 2020; 30(2): 180 doi: 10.1002/oa.2845
17
Yongchen Bie, Xiujun Zheng, Xiaojiong Chen, Xiangyun Liu, Liqin Wang, Yuanliang Sun, Jianqiang Kou. RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patientsJournal of Orthopaedic Surgery and Research 2023; 18(1) doi: 10.1186/s13018-023-03871-w
18
Adhraa S. Jaber, Ali H. Ad'hiah. A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitisCytokine 2023; 162: 156117 doi: 10.1016/j.cyto.2022.156117
19
Peter C. Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng, Annelies Boonen. A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing SpondylitisThe Journal of Rheumatology 2021; 48(8): 1259 doi: 10.3899/jrheum.201088
20
Philip J. Mease, Désirée van der Heijde, Chitra Karki, Mei Liu, Yujin Park, Jeffrey D. Greenberg. Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona RegistryRheumatology and Therapy 2018; 5(2): 537 doi: 10.1007/s40744-018-0129-z
21
Christopher S Kovacs. Complex clinical encounter series: osteoporosis presenting during pregnancy and lactation: wait and reassessJournal of Bone and Mineral Research 2024; 39(3): 197 doi: 10.1093/jbmr/zjae038
22
Yuliya Pepelyayeva, Andrea Amalfitano. The role of ERAP1 in autoinflammation and autoimmunityHuman Immunology 2019; 80(5): 302 doi: 10.1016/j.humimm.2019.02.013
23
Chaojie Yu, Xinli Zhan, Tuo Liang, Liyi Chen, Zide Zhang, Jie Jiang, Jiang Xue, Jiarui Chen, Chong Liu. Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and PhagosomeFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.572592
24
Masoumeh Mirrahimi, Caroline Ospelt. Fibroblasts - Advances in Inflammation, Autoimmunity and CancerBiochemistry 2021; 25 doi: 10.5772/intechopen.100298
25
Masatoshi YUNOKI, Kenta SUZUKI, Atsuhito UNEDA, Shuichi OKUBO, Koji HIRASHITA, Kimihiro YOSHINO. The Importance of Recognizing Diffuse Idiopathic Skeletal Hyperostosis for Neurosurgeons: A ReviewNeurologia medico-chirurgica 2016; 56(8): 510 doi: 10.2176/nmc.ra.2016-0013
26
Łukasz Jaśkiewicz, Grzegorz Chmielewski, Jakub Kuna, Tomasz Stompór, Magdalena Krajewska-Włodarczyk. The Role of Sclerostin in Rheumatic Diseases: A ReviewJournal of Clinical Medicine 2023; 12(19): 6248 doi: 10.3390/jcm12196248
27
Shigeto Kobayashi, Tomoko Kashiwagi, Junko Kimura. Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in JapanModern Rheumatology 2019; 29(6): 1007 doi: 10.1080/14397595.2018.1525024
28
Meryem YILMAZ KAYSIN, Ilknur AKTAS, Feyza UNLU OZKAN. A rare case of ankylosing spondylitis with severe temporomandibular joint and dental involvementMarmara Medical Journal 2017; 30(3): 181 doi: 10.5472/marumj.370860